Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses
Department of Urology, Mayo Clinic, Jacksonville, Florida, USA
Aug 2020 (Vol. 27, Issue 4, Pages( 10278 - 10284)
PMID: 32861252